A Multicenter Evaluation of the Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19
OBJECTIVES:. The Seraph100 Microbind Affinity Blood Filter (Seraph 100) (ExThera Medical, Martinez, CA) is an extracorporeal therapy that can remove pathogens from blood, including severe acute respiratory syndrome coronavirus 2. The aim of this study was to evaluate safety and efficacy of Seraph 10...
Similar Items
-
Sequential Extracorporeal Therapy of Pathogen Removal Followed by Cell-Directed Extracorporeal Therapy in Streptococcal Toxic Shock Syndrome Refractory to Venoarterial Extracorporeal Membrane Oxygenation: A Case Report
by: Stephen J. Amerson, MBA, et al.
Published: (2024-03-01) -
Masson's tumor of the reconstructed breast
by: Ian Klonk, MD, et al.
Published: (2023-05-01) -
Unusual cause of incessant atrial tachycardia
by: Emmanuel Ekanem, MD, et al.
Published: (2020-02-01) -
Keratotic spines in a patient with pruritic and dyskeratotic dermatosis: A new clinical finding
by: Kevin Kwan, BA, et al.
Published: (2021-01-01) -
Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma
by: Fatima Bawany, MD, et al.
Published: (2023-11-01)